| | 
Part, Chapter, Paragraph
1 II, 5. 5. 3| 241-246.~Grytten N, Glad SB, Aarseth JH, et al (2006):
2 II, 9. 1. 1| 319(7217):1093-7.~ ~Effer SB, Moutquin JM, Farine D,
3 II, 9. 1. 2| prevalence (including LB, SB and TOPFA) of 3.4 per 1
4 II, 9. 3. 2| 319(7217):1093-7.~ ~Effer SB, Moutquin JM, Farine D,
|
|
| |
